XTANT Medical Holdings Recalls nanOss 3D Advanced Bone Graft Substitute nanOss 3D Plus
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
XTANT Medical Holdings Recalls nanOss 3D Advanced Bone Graft Substitute nanOss 3D Plus
XTANT Medical Holdings, Inc · Class II — Moderate Risk

Product Description
nanOss 3D Advanced Bone Graft Substitute nanOss 3D Plus Advanced Bone Graft Substitute 90-300-251008: nanOss 3D Advanced Bone Graft Substitute, 25x100x8mm, 20cc 90-300-25508: nanOss 3D Advanced Bone Graft Substitute, 25x50x8mm, 10cc 90-300-251004: nanOss 3D Advanced Bone Graft Substitute, 25x100x4mm, 10cc 90-400-25508: nanOss 3D Plus Advanced Bone Graft Substitute, 25x50x8mm, 10cc
Reason for Recall
Products were incorrectly labeled with a 5-year shelf life. The approved and validated shelf life is four years.
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
US Nationwide distribution in the states and territories of CA, CT, DC, KS, MD, NC, NY, TX, and WI.
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
The FDA classified this recall as Class II, indicating the medical device may cause temporary health problems or poses a slight threat of a serious nature. XTANT Medical Holdings, Inc initiated the recall on March 9, 2026 affecting 225. Products were incorrectly labeled with a 5-year shelf life. The approved and validated shelf life is four years. The product was distributed nationwide. Consumers should check their purchases and discontinue use of any affected product. Contact XTANT Medical Holdings, Inc for further instructions.
Sources: FDA openFDA Enforcement Database
This recall appears in: Other Injury Hazards.